Sensible Biotechnologies Raises $47M to Expand Next-Generation Platform for mRNA Medicines

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 06 Oct, 11:05 UTC

Sensible Biotechnologies raised $47 million to scale VECTOR, its integrated platform pairing AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells, aiming to develop novel therapeutics beyond vaccines. The post Sensible Biotechnologies Raises $47M to Expand…

science

Sources

• T2Sensible Biotechnologies Raises $47M to Expand Next-Generation Platform for mRNA MedicinesFierce Biotech / Fierce Healthcare / MedCity / GEN06 Oct, 11:05